S&P 500
(-0.47%) 4 987.71 points
Dow Jones
(0.63%) 38 015 points
Nasdaq
(-1.39%) 15 385 points
Oil
(0.83%) $83.42
Gas
(-0.46%) $1.749
Gold
(0.63%) $2 413.00
Silver
(1.36%) $28.77
Platinum
(-1.19%) $943.10
USD/EUR
(-0.08%) $0.939
USD/NOK
(-0.19%) $11.02
USD/GBP
(0.43%) $0.807
USD/RUB
(-0.92%) $93.03

Realtime updates for Immunovant Inc [IMVT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
53.33%
return 0.59%
SELL
42.86%
return 2.13%
Last Updated19 Apr 2024 @ 13:25

-1.48% $ 27.90

SELL 66105 min ago

@ $35.47

Issued: 4 Mar 2024 @ 14:39


Return: -21.34%


Previous signal: Mar 1 - 13:21


Previous signal: Buy


Return: -1.61 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 13:25):

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia...

Stats
Today's Volume 401 756
Average Volume 1.16M
Market Cap 4.05B
EPS $0 ( 2024-02-16 )
Next earnings date ( $-0.430 ) 2024-05-27
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -15.41
ATR14 $0.0320 (0.11%)
Insider Trading
Date Person Action Amount type
2024-04-09 Barnett Eva Renee Sell 3 689 Common Stock
2024-04-09 Butchko Julia G. Sell 1 053 Common Stock
2024-04-09 Salzmann Peter Sell 4 807 Common Stock
2024-04-02 Fromkin Andrew J. Buy 11 255 Common Stock
2024-04-02 Fromkin Andrew J. Buy 4 690 Stock Option (right to buy)
INSIDER POWER
85.11
Last 99 transactions
Buy: 7 629 060 | Sell: 624 028

Volume Correlation

Long: -0.21 (neutral)
Short: 1.00 (very strong)
Signal:(49.023) Expect same movement, but be aware

Immunovant Inc Correlation

10 Most Positive Correlations
HZNP0.942
PMTS0.942
PEBK0.94
NWFL0.936
TBNK0.935
SNY0.935
WLFC0.934
ALOR0.931
MNKD0.925
LUNA0.925
10 Most Negative Correlations
RPID-0.941
USCB-0.94
PCRX-0.938
MEDS-0.938
NKTX-0.932
BOWXU-0.931
QLGN-0.93
STRC-0.93
GOSS-0.924
FATE-0.924

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunovant Inc Correlation - Currency/Commodity

The country flag 0.52
( weak )
The country flag 0.34
( neutral )
The country flag 0.00
( neutral )
The country flag -0.25
( neutral )
The country flag 0.46
( neutral )
The country flag -0.68
( moderate negative )

Immunovant Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-1.32M (0.00 %)
EPS: $-1.710
Q4 2023
Revenue: $0
Gross Profit: $-341 000 (0.00 %)
EPS: $-0.460
Q3 2023
Revenue: $0
Gross Profit: $-333 000 (0.00 %)
EPS: $-0.490
Q2 2023
Revenue: $0
Gross Profit: $-327 000 (0.00 %)
EPS: $-0.410

Financial Reports:

No articles found.

Immunovant Inc

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators